Centurion Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$250K Sell
8,761
-1,119
-11% -$29.8K 0.06% 243
2026
Q2
$238K Sell
9,880
-2,466
-20% -$64.5K 0.06% 255
2026
Q1
$347K Sell
12,346
-236
-2% -$6.28K 0.08% 208
2025
Q4
$313K Buy
12,582
+324
+3% +$8.17K 0.07% 230
2025
Q3
$312K Buy
+12,258
New +$303K 0.07% 221
2025
Q2
– Sell
-8,204
Closed -$218K – 245
2025
Q1
$218K Hold
8,204
– – 0.07% 195
2024
Q4
$218K Sell
8,204
-125
-2% -$3.39K 0.07% 195
2024
Q3
$241K Buy
+8,329
New +$243K 0.08% 180
2024
Q1
$365K Buy
13,160
+420
+3% +$11.7K 0.14% 106
2023
Q4
$367K Sell
12,740
-1,322
-9% -$40K 0.16% 102
2023
Q3
$466K Buy
14,062
+800
+6% +$28.3K 0.23% 76
2023
Q2
$486K Buy
13,262
+557
+4% +$21.7K 0.23% 75
2023
Q1
$518K Sell
12,705
-868
-6% -$37.5K 0.26% 70
2022
Q4
$695K Buy
+13,573
New +$651K 0.39% 55

Other funds holding PFE

Centurion Wealth Management's PFE Position: Q3 2026 in Review

Centurion Wealth Management reduced its Pfizer (PFE) stake by 11% in Q3 2026, selling an estimated $29.8K and leaving 8,761 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #243.

Centurion Wealth Management first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $695K in Q4 2022. 642 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Centurion Wealth Management held 8,761 shares of Pfizer worth $250K as of Q3 2026.
  • Centurion Wealth Management sold 1,119 Pfizer shares in Q3 2026, an estimated $29.8K.
  • Pfizer made up 0.06% of Centurion Wealth Management's portfolio in Q3 2026, its #243 holding.
  • Centurion Wealth Management first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Centurion Wealth Management's Pfizer position peaked at $695K in Q4 2022.
  • 642 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.